title: Cisplatin and continuous infusion vindesine and 5-fluorouracil in non-small cell lung cancer (NSCLC) (ATTIT 002). ATTIT (Association pour le Traitment des Tumeurs Intra-Thoraciques)
authors.forename: M
authors.initials: M
authors.lastname: Riggi
authors.forename: E
authors.initials: E
authors.lastname: Cvitkovic
authors.forename: H
authors.initials: H
authors.lastname: de Cremoux
authors.forename: P
authors.initials: P
authors.lastname: Ruffie
authors.forename: I
authors.initials: I
authors.lastname: Monnet
authors.forename: S
authors.initials: S
authors.lastname: Voisin
authors.forename: W
authors.initials: W
authors.lastname: Villalobos
authors.forename: N
authors.initials: N
authors.lastname: Azli
authors.forename: J C
authors.initials: JC
authors.lastname: Saltiel
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D016896:Treatment Outcome; D014751:Vindesine / Q000008:administration & dosage
chemical_list: D002945:Cisplatin; D014751:Vindesine; D005472:Fluorouracil